FDA-approved branded versions include Mounjaro (for type 2 diabetes) and Zepbound (for weight management)
Diabetes Care, 40(2), 78-85
35 divided by 100 equals 0.35 ml
Publications including preclinical and clinical evidence of GLP1, GLP1RAs and taste perception published in English and Spanish language were included
The recent approval of oral Wegovy in December 2025 expands alternatives for those preferring non-injective methods
"So I don't think it's the end of it, but it certainly will bring us into a new era after the time period has passed and all the lawsuits are finished." Pharmacies cry foul Scott Brunner, CEO of the Alliance for Pharmacy Compounding, which represents compounding pharmacists and technicians, questioned whether the FDA took into account the number of patients who will need to transition from compounded drugs to FDA-approved versions before making its announcement